Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
E45 Itch Relief Cream is a topical emollient and anti-pruritic formulation designed to treat dry, itchy skin conditions. It contains two active ingredients: **lauromacrogols** (3.0% w/w) and **urea** (5.0% w/w). Lauromacrogols act as a local anesthetic to desensitize peripheral sensory nerve endings, providing rapid relief from itching (pruritus). Urea is a naturally occurring humectant and keratolytic agent that helps the skin retain moisture and restores the skin's natural barrier function. The product is indicated for the treatment of pruritus, eczema (including atopic dermatitis), dermatitis, and scaling skin conditions. Originally developed and manufactured by Reckitt Benckiser Healthcare, the marketing authorization is currently held by Karo Pharma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lauromacrogols + urea.